Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spinal Neoplasms | 27 | 2024 | 715 | 3.710 |
Why?
|
Bone Neoplasms | 23 | 2024 | 2562 | 1.380 |
Why?
|
Drug-Eluting Stents | 5 | 2021 | 681 | 0.890 |
Why?
|
Fractures, Spontaneous | 7 | 2024 | 232 | 0.840 |
Why?
|
Sirolimus | 6 | 2021 | 1542 | 0.810 |
Why?
|
Cardiovascular Agents | 4 | 2021 | 849 | 0.810 |
Why?
|
Peripheral Arterial Disease | 9 | 2024 | 1299 | 0.800 |
Why?
|
Spinal Cord Compression | 3 | 2019 | 234 | 0.770 |
Why?
|
Coronary Artery Disease | 6 | 2024 | 6551 | 0.560 |
Why?
|
Epidural Abscess | 3 | 2023 | 94 | 0.500 |
Why?
|
Absorbable Implants | 4 | 2021 | 339 | 0.490 |
Why?
|
Coronary Restenosis | 3 | 2022 | 396 | 0.460 |
Why?
|
Postoperative Complications | 15 | 2021 | 15880 | 0.440 |
Why?
|
Angioplasty, Balloon | 3 | 2022 | 592 | 0.430 |
Why?
|
Soft Tissue Neoplasms | 4 | 2023 | 1166 | 0.420 |
Why?
|
Paclitaxel | 1 | 2019 | 1737 | 0.380 |
Why?
|
Spinal Fusion | 2 | 2019 | 1310 | 0.360 |
Why?
|
Sarcoma | 5 | 2018 | 1806 | 0.340 |
Why?
|
Limb Salvage | 2 | 2011 | 489 | 0.330 |
Why?
|
Stents | 2 | 2019 | 3204 | 0.320 |
Why?
|
Femoral Artery | 4 | 2022 | 829 | 0.320 |
Why?
|
Orthopedic Procedures | 5 | 2020 | 1280 | 0.320 |
Why?
|
Quality of Life | 7 | 2022 | 13497 | 0.310 |
Why?
|
MicroRNAs | 1 | 2024 | 3805 | 0.300 |
Why?
|
Chondrosarcoma | 2 | 2020 | 306 | 0.290 |
Why?
|
Femoral Neoplasms | 2 | 2017 | 85 | 0.280 |
Why?
|
Models, Molecular | 15 | 2008 | 5443 | 0.270 |
Why?
|
Retrospective Studies | 41 | 2024 | 81834 | 0.250 |
Why?
|
Salvage Therapy | 1 | 2011 | 1277 | 0.240 |
Why?
|
Algorithms | 8 | 2024 | 14158 | 0.230 |
Why?
|
Walking | 3 | 2022 | 1202 | 0.230 |
Why?
|
Middle Aged | 56 | 2024 | 223418 | 0.230 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2006 | 369 | 0.220 |
Why?
|
Liposarcoma, Myxoid | 1 | 2023 | 60 | 0.220 |
Why?
|
Treatment Outcome | 27 | 2023 | 65409 | 0.210 |
Why?
|
Humans | 98 | 2024 | 768451 | 0.210 |
Why?
|
Atherectomy, Coronary | 1 | 2022 | 138 | 0.210 |
Why?
|
Aged | 47 | 2024 | 171520 | 0.200 |
Why?
|
Antiviral Agents | 7 | 2008 | 3063 | 0.200 |
Why?
|
Palliative Care | 1 | 2017 | 3644 | 0.200 |
Why?
|
Extremities | 4 | 2023 | 870 | 0.200 |
Why?
|
Spine | 5 | 2020 | 1142 | 0.200 |
Why?
|
Molecular Weight | 2 | 2021 | 2173 | 0.190 |
Why?
|
Spinal Fractures | 2 | 2019 | 712 | 0.190 |
Why?
|
Liposarcoma | 1 | 2023 | 289 | 0.180 |
Why?
|
Hypoalbuminemia | 1 | 2021 | 90 | 0.180 |
Why?
|
Neurosurgical Procedures | 4 | 2019 | 2097 | 0.170 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2022 | 9425 | 0.170 |
Why?
|
Intermittent Claudication | 2 | 2012 | 305 | 0.170 |
Why?
|
Flaviviridae | 3 | 2008 | 9 | 0.170 |
Why?
|
Male | 58 | 2024 | 364781 | 0.170 |
Why?
|
Prosthesis Design | 3 | 2021 | 2126 | 0.170 |
Why?
|
Female | 56 | 2024 | 396943 | 0.160 |
Why?
|
Lower Extremity | 5 | 2012 | 1214 | 0.160 |
Why?
|
Fracture Fixation, Internal | 2 | 2016 | 981 | 0.160 |
Why?
|
Fibromatosis, Aggressive | 1 | 2020 | 125 | 0.160 |
Why?
|
Prospective Studies | 15 | 2022 | 54914 | 0.160 |
Why?
|
Cervical Atlas | 1 | 2018 | 22 | 0.160 |
Why?
|
Atherectomy | 2 | 2021 | 42 | 0.150 |
Why?
|
Iliac Artery | 1 | 2020 | 344 | 0.150 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2018 | 114 | 0.150 |
Why?
|
Chondroblastoma | 1 | 2018 | 47 | 0.150 |
Why?
|
Lordosis | 1 | 2019 | 97 | 0.150 |
Why?
|
Genetic Markers | 1 | 2024 | 2604 | 0.150 |
Why?
|
Popliteal Artery | 2 | 2021 | 313 | 0.150 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2020 | 284 | 0.150 |
Why?
|
Bone Diseases | 1 | 2021 | 418 | 0.150 |
Why?
|
Mutation, Missense | 2 | 2006 | 2594 | 0.150 |
Why?
|
Lumbosacral Region | 1 | 2019 | 294 | 0.140 |
Why?
|
Acute Coronary Syndrome | 2 | 2020 | 2195 | 0.140 |
Why?
|
Osteosarcoma | 2 | 2020 | 912 | 0.140 |
Why?
|
Platelet Aggregation | 1 | 2020 | 772 | 0.140 |
Why?
|
Humeral Head | 1 | 2017 | 41 | 0.140 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2018 | 119 | 0.140 |
Why?
|
Prognosis | 14 | 2024 | 30028 | 0.140 |
Why?
|
Chemoprevention | 1 | 2019 | 326 | 0.140 |
Why?
|
Nomograms | 2 | 2016 | 236 | 0.140 |
Why?
|
Leg Bones | 1 | 2016 | 19 | 0.140 |
Why?
|
Reoperation | 5 | 2018 | 4342 | 0.140 |
Why?
|
Lung Neoplasms | 6 | 2019 | 13589 | 0.140 |
Why?
|
Polymers | 2 | 2019 | 1631 | 0.140 |
Why?
|
Adult | 38 | 2024 | 223542 | 0.140 |
Why?
|
Myocardial Revascularization | 1 | 2020 | 796 | 0.130 |
Why?
|
Muramidase | 2 | 2006 | 165 | 0.130 |
Why?
|
Biomedical Technology | 1 | 2019 | 210 | 0.130 |
Why?
|
Mobility Limitation | 1 | 2020 | 409 | 0.130 |
Why?
|
Equipment and Supplies | 1 | 2019 | 273 | 0.130 |
Why?
|
Humerus | 1 | 2018 | 273 | 0.130 |
Why?
|
Silicon | 2 | 2006 | 143 | 0.130 |
Why?
|
Serum Albumin | 2 | 2017 | 676 | 0.130 |
Why?
|
Risk Factors | 18 | 2024 | 74915 | 0.130 |
Why?
|
Amides | 3 | 2007 | 452 | 0.130 |
Why?
|
Alkaline Phosphatase | 1 | 2019 | 865 | 0.130 |
Why?
|
Ligaments, Articular | 1 | 2018 | 304 | 0.130 |
Why?
|
RNA Viruses | 2 | 2007 | 110 | 0.130 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2006 | 2964 | 0.130 |
Why?
|
Multiple Trauma | 1 | 2018 | 370 | 0.130 |
Why?
|
Injury Severity Score | 1 | 2019 | 1053 | 0.120 |
Why?
|
Survival Rate | 8 | 2024 | 12875 | 0.120 |
Why?
|
Membranes, Artificial | 2 | 2006 | 367 | 0.120 |
Why?
|
Computer Simulation | 8 | 2008 | 6278 | 0.120 |
Why?
|
Fractures, Bone | 2 | 2018 | 2063 | 0.120 |
Why?
|
Physical Endurance | 1 | 2017 | 370 | 0.120 |
Why?
|
Arthroplasty | 1 | 2017 | 310 | 0.120 |
Why?
|
Coronary Stenosis | 1 | 2020 | 803 | 0.110 |
Why?
|
Pelvic Bones | 1 | 2016 | 270 | 0.110 |
Why?
|
Survival Analysis | 7 | 2024 | 10125 | 0.110 |
Why?
|
Thymosin | 1 | 2013 | 47 | 0.110 |
Why?
|
Patient Selection | 4 | 2020 | 4266 | 0.110 |
Why?
|
Drug Delivery Systems | 3 | 2019 | 2238 | 0.110 |
Why?
|
Orthopedics | 1 | 2022 | 906 | 0.110 |
Why?
|
Antitubercular Agents | 3 | 2007 | 1390 | 0.110 |
Why?
|
Carcinoma, Renal Cell | 2 | 2020 | 3197 | 0.110 |
Why?
|
Severity of Illness Index | 5 | 2024 | 15965 | 0.110 |
Why?
|
Mortality | 3 | 2020 | 2917 | 0.100 |
Why?
|
Secondary Prevention | 1 | 2019 | 1479 | 0.100 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2017 | 347 | 0.100 |
Why?
|
Humeral Fractures | 1 | 2015 | 283 | 0.100 |
Why?
|
Case-Control Studies | 4 | 2024 | 22293 | 0.100 |
Why?
|
Diabetes Mellitus | 2 | 2024 | 5887 | 0.100 |
Why?
|
Femoral Fractures | 1 | 2016 | 376 | 0.100 |
Why?
|
Endothelium, Vascular | 1 | 2024 | 4425 | 0.100 |
Why?
|
Ankle Brachial Index | 1 | 2012 | 163 | 0.100 |
Why?
|
Kidney Neoplasms | 2 | 2020 | 4298 | 0.100 |
Why?
|
Antifungal Agents | 2 | 2007 | 761 | 0.100 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2017 | 614 | 0.090 |
Why?
|
Endothelial Cells | 1 | 2024 | 3586 | 0.090 |
Why?
|
Molecular Structure | 8 | 2007 | 1889 | 0.090 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 1 | 2011 | 94 | 0.090 |
Why?
|
Internationality | 1 | 2017 | 1007 | 0.090 |
Why?
|
Health Status Indicators | 1 | 2016 | 971 | 0.090 |
Why?
|
Aged, 80 and over | 15 | 2021 | 59680 | 0.090 |
Why?
|
Awards and Prizes | 1 | 2015 | 365 | 0.090 |
Why?
|
Thoracic Vertebrae | 1 | 2015 | 613 | 0.090 |
Why?
|
Imidazoles | 2 | 2007 | 1174 | 0.090 |
Why?
|
Aortic Valve Stenosis | 1 | 2023 | 2032 | 0.090 |
Why?
|
Advisory Committees | 1 | 2015 | 797 | 0.090 |
Why?
|
Joint Instability | 1 | 2018 | 802 | 0.090 |
Why?
|
Leg | 1 | 2015 | 1089 | 0.090 |
Why?
|
Models, Chemical | 3 | 2007 | 611 | 0.090 |
Why?
|
Antineoplastic Agents | 5 | 2019 | 13708 | 0.090 |
Why?
|
Endovascular Procedures | 1 | 2024 | 2258 | 0.090 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2019 | 2067 | 0.090 |
Why?
|
Angioplasty | 1 | 2012 | 357 | 0.090 |
Why?
|
RNA Helicases | 2 | 2007 | 144 | 0.080 |
Why?
|
Neoplasm Metastasis | 5 | 2019 | 4931 | 0.080 |
Why?
|
Decision Support Techniques | 1 | 2020 | 2010 | 0.080 |
Why?
|
Pain Measurement | 2 | 2017 | 3577 | 0.080 |
Why?
|
Athletes | 1 | 2017 | 1162 | 0.080 |
Why?
|
Protein Precursors | 1 | 2013 | 1133 | 0.080 |
Why?
|
Surgical Wound Infection | 2 | 2016 | 1544 | 0.080 |
Why?
|
Blood Transfusion | 1 | 2016 | 1308 | 0.080 |
Why?
|
England | 2 | 2021 | 533 | 0.080 |
Why?
|
Time Factors | 9 | 2021 | 40271 | 0.080 |
Why?
|
Ventricular Function, Left | 2 | 2023 | 3941 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2020 | 2768 | 0.080 |
Why?
|
Pneumonectomy | 1 | 2015 | 1159 | 0.080 |
Why?
|
Neoplasms | 1 | 2017 | 22386 | 0.080 |
Why?
|
Umbelliferones | 1 | 2007 | 12 | 0.080 |
Why?
|
Picornaviridae | 1 | 2007 | 14 | 0.080 |
Why?
|
Adenine Nucleotides | 1 | 2008 | 110 | 0.080 |
Why?
|
Carcinoma | 1 | 2019 | 2341 | 0.070 |
Why?
|
Hyperthermia, Induced | 1 | 2011 | 417 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 2 | 2016 | 6537 | 0.070 |
Why?
|
Drug Design | 4 | 2008 | 1050 | 0.070 |
Why?
|
Follow-Up Studies | 9 | 2024 | 39430 | 0.070 |
Why?
|
Histones | 1 | 2018 | 2595 | 0.070 |
Why?
|
Diabetic Angiopathies | 1 | 2012 | 806 | 0.070 |
Why?
|
Candida glabrata | 1 | 2007 | 38 | 0.070 |
Why?
|
Phenanthrolines | 1 | 2007 | 49 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2834 | 0.070 |
Why?
|
Knee | 1 | 2009 | 279 | 0.070 |
Why?
|
Lymphocyte Count | 2 | 2019 | 793 | 0.070 |
Why?
|
Mycobacterium tuberculosis | 3 | 2007 | 1931 | 0.070 |
Why?
|
Area Under Curve | 2 | 2024 | 1640 | 0.070 |
Why?
|
Biocompatible Materials | 2 | 2006 | 1703 | 0.070 |
Why?
|
ROC Curve | 3 | 2024 | 3624 | 0.070 |
Why?
|
Ischemia | 1 | 2015 | 1900 | 0.070 |
Why?
|
Platelet Count | 2 | 2019 | 786 | 0.070 |
Why?
|
Disease Management | 1 | 2017 | 2533 | 0.070 |
Why?
|
Radiosurgery | 1 | 2016 | 1354 | 0.070 |
Why?
|
Endarterectomy, Carotid | 1 | 2011 | 558 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2291 | 0.070 |
Why?
|
Venous Thromboembolism | 1 | 2019 | 1884 | 0.060 |
Why?
|
Keto Acids | 1 | 2005 | 34 | 0.060 |
Why?
|
Blotting, Southern | 1 | 2006 | 777 | 0.060 |
Why?
|
Preoperative Period | 2 | 2019 | 564 | 0.060 |
Why?
|
Melanoma | 1 | 2024 | 5740 | 0.060 |
Why?
|
Combined Modality Therapy | 2 | 2020 | 8559 | 0.060 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2006 | 381 | 0.060 |
Why?
|
Piperazines | 2 | 2006 | 2546 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2013 | 2465 | 0.060 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2011 | 1724 | 0.060 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2006 | 170 | 0.060 |
Why?
|
Structure-Activity Relationship | 5 | 2008 | 3073 | 0.060 |
Why?
|
Thermodynamics | 1 | 2006 | 594 | 0.060 |
Why?
|
Myocytes, Cardiac | 1 | 2013 | 1683 | 0.060 |
Why?
|
Reproducibility of Results | 5 | 2023 | 20231 | 0.060 |
Why?
|
Candida albicans | 1 | 2007 | 376 | 0.060 |
Why?
|
Carotid Stenosis | 1 | 2011 | 864 | 0.060 |
Why?
|
Brachytherapy | 1 | 2011 | 1227 | 0.060 |
Why?
|
Phosphonoacetic Acid | 1 | 2003 | 54 | 0.060 |
Why?
|
Enzyme Inhibitors | 2 | 2005 | 3734 | 0.060 |
Why?
|
Polyamines | 1 | 2004 | 133 | 0.060 |
Why?
|
Decision Making | 1 | 2017 | 3961 | 0.060 |
Why?
|
Anticoagulants | 1 | 2019 | 4840 | 0.050 |
Why?
|
Contrast Media | 1 | 2017 | 5336 | 0.050 |
Why?
|
Pyrimidines | 2 | 2006 | 3050 | 0.050 |
Why?
|
Cyclodextrins | 1 | 2003 | 63 | 0.050 |
Why?
|
Logistic Models | 4 | 2019 | 13324 | 0.050 |
Why?
|
Risk Assessment | 6 | 2020 | 24311 | 0.050 |
Why?
|
Patient Readmission | 1 | 2017 | 3308 | 0.050 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2005 | 430 | 0.050 |
Why?
|
Ribonucleotide Reductases | 1 | 2003 | 75 | 0.050 |
Why?
|
Young Adult | 10 | 2020 | 60045 | 0.050 |
Why?
|
Stroke Volume | 1 | 2017 | 5620 | 0.050 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2006 | 1688 | 0.050 |
Why?
|
Myocardial Ischemia | 1 | 2013 | 2139 | 0.050 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2012 | 1252 | 0.050 |
Why?
|
Adolescent | 7 | 2020 | 89168 | 0.050 |
Why?
|
Hemeproteins | 1 | 2002 | 61 | 0.050 |
Why?
|
Bone Transplantation | 2 | 2018 | 925 | 0.050 |
Why?
|
Esters | 1 | 2003 | 212 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2006 | 727 | 0.050 |
Why?
|
Protoporphyrins | 1 | 2002 | 170 | 0.050 |
Why?
|
Cohort Studies | 6 | 2022 | 41797 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2018 | 10358 | 0.050 |
Why?
|
Postoperative Period | 2 | 2018 | 1833 | 0.050 |
Why?
|
Hexokinase | 2 | 1992 | 124 | 0.050 |
Why?
|
Gene Amplification | 1 | 2006 | 1091 | 0.050 |
Why?
|
Anxiety | 1 | 2016 | 4655 | 0.050 |
Why?
|
Hypercalcemia | 1 | 2024 | 423 | 0.050 |
Why?
|
Equipment Design | 2 | 2020 | 3530 | 0.050 |
Why?
|
Nanostructures | 1 | 2006 | 553 | 0.050 |
Why?
|
Heart Diseases | 1 | 2014 | 2816 | 0.040 |
Why?
|
Triazoles | 1 | 2006 | 905 | 0.040 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2005 | 687 | 0.040 |
Why?
|
Materials Testing | 2 | 2020 | 871 | 0.040 |
Why?
|
Models, Biological | 2 | 2006 | 9505 | 0.040 |
Why?
|
Predictive Value of Tests | 4 | 2020 | 15460 | 0.040 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2006 | 617 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2017 | 9066 | 0.040 |
Why?
|
Reference Values | 2 | 2017 | 4941 | 0.040 |
Why?
|
Drug Carriers | 1 | 2004 | 712 | 0.040 |
Why?
|
Colombia | 1 | 2020 | 285 | 0.040 |
Why?
|
Protein Structure, Tertiary | 4 | 2007 | 3790 | 0.040 |
Why?
|
Coated Materials, Biocompatible | 1 | 2021 | 311 | 0.040 |
Why?
|
Lymphoma | 2 | 2019 | 1907 | 0.040 |
Why?
|
Physicians | 1 | 2017 | 4615 | 0.040 |
Why?
|
Albumins | 1 | 2021 | 578 | 0.040 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2006 | 1376 | 0.040 |
Why?
|
Mutation | 2 | 2018 | 30243 | 0.040 |
Why?
|
Recovery of Function | 2 | 2020 | 2994 | 0.040 |
Why?
|
Platelet Function Tests | 1 | 2020 | 272 | 0.040 |
Why?
|
Cell Line | 6 | 2008 | 15609 | 0.040 |
Why?
|
Coronary Angiography | 2 | 2020 | 4526 | 0.040 |
Why?
|
Hepacivirus | 1 | 2005 | 1342 | 0.040 |
Why?
|
Vascular Patency | 1 | 2021 | 916 | 0.040 |
Why?
|
Protein Conformation | 1 | 2006 | 3973 | 0.040 |
Why?
|
Italy | 1 | 2020 | 853 | 0.040 |
Why?
|
Necrosis | 1 | 2022 | 1621 | 0.040 |
Why?
|
Body Mass Index | 1 | 2016 | 13030 | 0.040 |
Why?
|
Arthrodesis | 1 | 2019 | 186 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11843 | 0.040 |
Why?
|
Swine, Miniature | 1 | 2020 | 965 | 0.040 |
Why?
|
Polyethylene Glycols | 1 | 2003 | 1195 | 0.040 |
Why?
|
Molecular Conformation | 3 | 2003 | 542 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3253 | 0.040 |
Why?
|
Apoptosis | 1 | 2013 | 9526 | 0.040 |
Why?
|
Sacrum | 1 | 2019 | 276 | 0.040 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2019 | 344 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 20762 | 0.030 |
Why?
|
Neoadjuvant Therapy | 2 | 2022 | 2896 | 0.030 |
Why?
|
Tomography, Optical Coherence | 2 | 2020 | 2958 | 0.030 |
Why?
|
Depression | 1 | 2016 | 8235 | 0.030 |
Why?
|
Aftercare | 1 | 2023 | 921 | 0.030 |
Why?
|
Binding Sites | 4 | 2007 | 6030 | 0.030 |
Why?
|
Folic Acid | 1 | 2003 | 1336 | 0.030 |
Why?
|
Phosphorylation | 2 | 2006 | 8332 | 0.030 |
Why?
|
Radiography | 2 | 2019 | 6995 | 0.030 |
Why?
|
Florida | 1 | 2017 | 430 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2279 | 0.030 |
Why?
|
Fractures, Stress | 1 | 2018 | 205 | 0.030 |
Why?
|
Operating Rooms | 1 | 2022 | 799 | 0.030 |
Why?
|
Embolism, Fat | 1 | 2015 | 46 | 0.030 |
Why?
|
Climate Change | 1 | 2022 | 510 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2023 | 2216 | 0.030 |
Why?
|
Odds Ratio | 2 | 2019 | 9687 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2012 | 1794 | 0.030 |
Why?
|
Patients | 1 | 2022 | 909 | 0.030 |
Why?
|
Fracture Fixation | 1 | 2017 | 371 | 0.030 |
Why?
|
Morbidity | 1 | 2020 | 1760 | 0.030 |
Why?
|
Posture | 1 | 2019 | 956 | 0.030 |
Why?
|
Artificial Limbs | 1 | 2016 | 121 | 0.030 |
Why?
|
Pelvis | 1 | 2019 | 737 | 0.030 |
Why?
|
Fracture Healing | 1 | 2017 | 448 | 0.030 |
Why?
|
Drug Resistance | 1 | 2020 | 1599 | 0.030 |
Why?
|
Decompression, Surgical | 1 | 2019 | 612 | 0.030 |
Why?
|
Fracture Fixation, Intramedullary | 1 | 2016 | 160 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 2 | 2006 | 467 | 0.030 |
Why?
|
Cricetinae | 2 | 2008 | 2423 | 0.030 |
Why?
|
Pulmonary Embolism | 2 | 2019 | 2591 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 2016 | 1007 | 0.030 |
Why?
|
Models, Animal | 1 | 2020 | 2126 | 0.030 |
Why?
|
Treatment Failure | 1 | 2019 | 2656 | 0.030 |
Why?
|
Aortic Valve | 1 | 2023 | 1968 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 3 | 2023 | 36840 | 0.030 |
Why?
|
Cell Survival | 3 | 2007 | 5801 | 0.030 |
Why?
|
Biopsy, Fine-Needle | 1 | 2018 | 1131 | 0.030 |
Why?
|
Hexosephosphates | 1 | 1992 | 24 | 0.030 |
Why?
|
Accidents, Traffic | 1 | 2018 | 821 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2019 | 21156 | 0.020 |
Why?
|
Myocardial Contraction | 1 | 2017 | 1527 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2020 | 2358 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2020 | 2226 | 0.020 |
Why?
|
Range of Motion, Articular | 1 | 2018 | 1599 | 0.020 |
Why?
|
Cell Hypoxia | 1 | 2013 | 661 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2018 | 2925 | 0.020 |
Why?
|
Protein Transport | 2 | 2006 | 1963 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2018 | 2930 | 0.020 |
Why?
|
Hemoglobins | 1 | 2017 | 1532 | 0.020 |
Why?
|
Radiotherapy | 1 | 2017 | 1510 | 0.020 |
Why?
|
Multiple Myeloma | 2 | 2019 | 5192 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 2 | 2007 | 1965 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12561 | 0.020 |
Why?
|
Benzamides | 2 | 2006 | 1381 | 0.020 |
Why?
|
Shoulder Joint | 1 | 2017 | 749 | 0.020 |
Why?
|
Swine | 1 | 2020 | 5996 | 0.020 |
Why?
|
Patient Discharge | 1 | 2023 | 3471 | 0.020 |
Why?
|
Venous Thrombosis | 1 | 2019 | 1318 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 4120 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2012 | 591 | 0.020 |
Why?
|
Mass Spectrometry | 2 | 2008 | 2204 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3906 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2016 | 1839 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2005 | 5709 | 0.020 |
Why?
|
Observer Variation | 1 | 2015 | 2622 | 0.020 |
Why?
|
Aspirin | 1 | 2020 | 3139 | 0.020 |
Why?
|
Diarrhea Viruses, Bovine Viral | 1 | 2008 | 6 | 0.020 |
Why?
|
Tetrazolium Salts | 1 | 2008 | 92 | 0.020 |
Why?
|
Chromatography, Thin Layer | 1 | 2008 | 213 | 0.020 |
Why?
|
Mannich Bases | 1 | 2007 | 2 | 0.020 |
Why?
|
Thrombophlebitis | 1 | 2009 | 289 | 0.020 |
Why?
|
Databases, Factual | 2 | 2017 | 8081 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2017 | 4834 | 0.020 |
Why?
|
Prevalence | 2 | 2017 | 15880 | 0.020 |
Why?
|
Surgical Wound Dehiscence | 1 | 2009 | 216 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2012 | 1196 | 0.020 |
Why?
|
Upper Extremity | 1 | 2012 | 682 | 0.020 |
Why?
|
Entropy | 1 | 2008 | 212 | 0.020 |
Why?
|
Skin Transplantation | 1 | 2012 | 1097 | 0.020 |
Why?
|
Indicators and Reagents | 1 | 2008 | 455 | 0.020 |
Why?
|
Enterovirus | 1 | 2007 | 69 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3637 | 0.020 |
Why?
|
Linear Models | 1 | 2017 | 5880 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9361 | 0.020 |
Why?
|
Magnesium Hydroxide | 1 | 2006 | 9 | 0.020 |
Why?
|
Adsorption | 1 | 2006 | 198 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8730 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2008 | 3783 | 0.020 |
Why?
|
Aluminum Hydroxide | 1 | 2006 | 54 | 0.020 |
Why?
|
Animals | 7 | 2020 | 169418 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2008 | 506 | 0.020 |
Why?
|
Carotid Artery Diseases | 1 | 2012 | 879 | 0.020 |
Why?
|
Viral Nonstructural Proteins | 1 | 2007 | 229 | 0.020 |
Why?
|
Binding, Competitive | 1 | 2007 | 1144 | 0.020 |
Why?
|
Quantitative Structure-Activity Relationship | 1 | 2005 | 28 | 0.020 |
Why?
|
Diabetes Complications | 1 | 2012 | 1322 | 0.020 |
Why?
|
Isoleucine | 1 | 2005 | 112 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2008 | 720 | 0.020 |
Why?
|
Lumbar Vertebrae | 1 | 2015 | 1885 | 0.020 |
Why?
|
Candida | 1 | 2006 | 172 | 0.020 |
Why?
|
Sciatic Nerve | 1 | 2009 | 628 | 0.020 |
Why?
|
Kidney | 1 | 2020 | 7064 | 0.020 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2007 | 423 | 0.010 |
Why?
|
Diffusion | 1 | 2006 | 818 | 0.010 |
Why?
|
Spectrum Analysis | 1 | 2007 | 450 | 0.010 |
Why?
|
Threonine | 1 | 2005 | 274 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2024 | 5891 | 0.010 |
Why?
|
Models, Statistical | 1 | 2019 | 5103 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2013 | 6241 | 0.010 |
Why?
|
Death, Sudden, Cardiac | 1 | 2012 | 1568 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11138 | 0.010 |
Why?
|
Surgical Flaps | 1 | 2012 | 1683 | 0.010 |
Why?
|
Pneumonia | 1 | 2015 | 2162 | 0.010 |
Why?
|
Chemistry, Physical | 1 | 2003 | 153 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4362 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12096 | 0.010 |
Why?
|
Chemical Phenomena | 1 | 2003 | 486 | 0.010 |
Why?
|
Health Status | 1 | 2016 | 4096 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 13026 | 0.010 |
Why?
|
Solvents | 1 | 2004 | 298 | 0.010 |
Why?
|
Nucleosides | 1 | 2003 | 131 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2008 | 1339 | 0.010 |
Why?
|
Dogs | 1 | 2007 | 3847 | 0.010 |
Why?
|
Escherichia coli | 2 | 1992 | 4220 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2014 | 3145 | 0.010 |
Why?
|
Cattle | 1 | 2008 | 3830 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2012 | 6856 | 0.010 |
Why?
|
Child | 2 | 2020 | 80863 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10784 | 0.010 |
Why?
|
Wound Healing | 1 | 2012 | 2819 | 0.010 |
Why?
|
Molecular Mimicry | 1 | 2002 | 214 | 0.010 |
Why?
|
Surface Properties | 1 | 2004 | 1168 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2018 | 9263 | 0.010 |
Why?
|
Thiazoles | 1 | 2008 | 1541 | 0.010 |
Why?
|
Myocardium | 1 | 2013 | 4788 | 0.010 |
Why?
|
Ligands | 1 | 2007 | 3281 | 0.010 |
Why?
|
Electrocardiography | 1 | 2014 | 6410 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2009 | 3550 | 0.010 |
Why?
|
Recurrence | 1 | 2012 | 8510 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2002 | 1435 | 0.010 |
Why?
|
Stroke | 2 | 2012 | 9791 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18478 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 1992 | 1734 | 0.010 |
Why?
|
Ultrasonography | 1 | 2012 | 5995 | 0.010 |
Why?
|
Registries | 1 | 2015 | 8373 | 0.010 |
Why?
|
Skin | 1 | 2012 | 4520 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 1991 | 3861 | 0.010 |
Why?
|
Proteins | 1 | 1991 | 6008 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2011 | 8051 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 26351 | 0.010 |
Why?
|
Protein Binding | 1 | 2007 | 9376 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2008 | 4419 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7451 | 0.010 |
Why?
|
Computational Biology | 1 | 2005 | 3546 | 0.010 |
Why?
|
Placenta | 2 | 1992 | 1724 | 0.010 |
Why?
|
Chromatography, Ion Exchange | 1 | 1992 | 294 | 0.010 |
Why?
|
Mice | 2 | 2013 | 82045 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2012 | 11515 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2006 | 5342 | 0.010 |
Why?
|
Base Sequence | 2 | 1992 | 12428 | 0.010 |
Why?
|
Oxygen | 1 | 2002 | 4269 | 0.010 |
Why?
|
Catalysis | 1 | 1992 | 769 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 1992 | 13452 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1991 | 1553 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 1992 | 17647 | 0.010 |
Why?
|
Open Reading Frames | 1 | 1992 | 812 | 0.000 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1992 | 1543 | 0.000 |
Why?
|
Cell Line, Tumor | 1 | 2003 | 17149 | 0.000 |
Why?
|
Enzyme Activation | 1 | 1992 | 3594 | 0.000 |
Why?
|
Cloning, Molecular | 1 | 1991 | 4175 | 0.000 |
Why?
|
HIV-1 | 1 | 2003 | 6966 | 0.000 |
Why?
|
Blotting, Western | 1 | 1992 | 5042 | 0.000 |
Why?
|
Kinetics | 1 | 1992 | 6348 | 0.000 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1991 | 3816 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1992 | 6527 | 0.000 |
Why?
|
DNA | 1 | 1992 | 7213 | 0.000 |
Why?
|
Pregnancy | 1 | 1992 | 30179 | 0.000 |
Why?
|